Publicaciones
TELÉFONOS HOSPITAL LUCUS AUGUSTI
982 295475
982 297029
982 266480
982 296008
09 de Diciembre de 2021
Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma.
Expert Rev Respir Med. 2021 Nov 16. doi: 10.1080/17476348.2021.2005585. Epub ahead of print. PMID: 34783265
09 de Diciembre de 2021
Efficacy of mepolizumab in usual clinical practice and characteristics of responders
Respir Med. 2021 Oct;187:106595. doi: 10.1016/j.rmed.2021.106595. Epub 2021 Sep 2. PMID: 34492540.
09 de Diciembre de 2021
Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities.
J Allergy Clin Immunol Pract. 2021 Aug 14:S2213-2198(21)00897-7. doi: 10.1016/j.jaip.2021.07.056. Epub ahead of print. PMID: 34403837.
09 de Diciembre de 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Chest. 2021 Sep;160(3):814-830. doi: 10.1016/j.chest.2021.04.013. Epub 2021 Apr 19. PMID: 33887242.
09 de Diciembre de 2021
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry. J Allergy Clin Immunol Pract
2021 Jul;9(7):2680-2688.e7. doi: 10.1016/j.jaip.2021.02.059. Epub 2021 Mar 18. Erratum in: J Allergy Clin Immunol Pract. 2021 Nov;9(11):4182. PMID: 33744476.
09 de Diciembre de 2021
Phenotype- Guided Asthma Therapy: An Alternative Approach to Guidelines. J Asthma Allergy.
2021 Mar 12;14:207-217. doi: 10.2147/JAA.S266999. PMID: 33737814; PMCID: PMC7966411.
